ロード中...
In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
Ceftazidime/avibactam is an important treatment option for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-Kp), however, resistance can emerge during treatment. The objective of the study was to define the ceftazidime/avibactam concentrations required to suppres...
保存先:
| 出版年: | Front Microbiol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7982837/ https://ncbi.nlm.nih.gov/pubmed/33763041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2021.618087 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|